Tags

Type your tag names separated by a space and hit enter

Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.
PLoS One. 2011 Mar 21; 6(3):e17953.Plos

Abstract

Tauopathic pathways lead to degenerative changes in Alzheimer's disease and there is evidence that they are also involved in the neurodegenerative pathology of Parkinson's disease [PD]. We have examined tauopathic changes in striatum of the α-synuclein (α-Syn) A53T mutant mouse. Elevated levels of α-Syn were observed in striatum of the adult A53T α-Syn mice. This was accompanied by increases in hyperphosphorylated Tau [p-Tau], phosphorylated at Ser202, Ser262 and Ser396/404, which are the same toxic sites also seen in Alzheimer's disease. There was an increase in active p-GSK-3β, hyperphosphorylated at Tyr216, a major and primary kinase known to phosphorylate Tau at multiple sites. The sites of hyperphosphorylation of Tau in the A53T mutant mice were similar to those seen in post-mortem striata from PD patients, attesting to their pathophysiological relevance. Increases in p-Tau were not due to alterations on protein phosphatases in either A53T mice or in human PD, suggesting lack of involvement of these proteins in tauopathy. Extraction of striata with Triton X-100 showed large increases in oligomeric forms of α-Syn suggesting that α-Syn had formed aggregates the mutant mice. In addition, increased levels of p-GSK-3β and pSer396/404 were also found associated with aggregated α-Syn. Differential solubilization to measure protein binding to cytoskeletal proteins demonstrated that p-Tau in the A53T mutant mouse were unbound to cytoskeletal proteins, consistent with dissociation of p-Tau from the microtubules upon hyperphosphorylation. Interestingly, α-Syn remained tightly bound to the cytoskeleton, while p-GSK-3β was seen in the cytoskeleton-free fractions. Immunohistochemical studies showed that α-Syn, pSer396/404 Tau and p-GSK-3β co-localized with one another and was aggregated and accumulated into large inclusion bodies, leading to cell death of Substantia nigral neurons. Together, these data demonstrate an elevated state of tauopathy in striata of the A53T α-Syn mutant mice, suggesting that tauopathy is a common feature of synucleinopathies.

Authors+Show Affiliations

Department of Biochemistry, Molecular and Cellular Biology, Georgetown University, Washington, DC, United States of America.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21445308

Citation

Wills, Jonathan, et al. "Tauopathic Changes in the Striatum of A53T Α-synuclein Mutant Mouse Model of Parkinson's Disease." PloS One, vol. 6, no. 3, 2011, pp. e17953.
Wills J, Credle J, Haggerty T, et al. Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. PLoS One. 2011;6(3):e17953.
Wills, J., Credle, J., Haggerty, T., Lee, J. H., Oaks, A. W., & Sidhu, A. (2011). Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. PloS One, 6(3), e17953. https://doi.org/10.1371/journal.pone.0017953
Wills J, et al. Tauopathic Changes in the Striatum of A53T Α-synuclein Mutant Mouse Model of Parkinson's Disease. PLoS One. 2011 Mar 21;6(3):e17953. PubMed PMID: 21445308.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease. AU - Wills,Jonathan, AU - Credle,Joel, AU - Haggerty,Thomas, AU - Lee,Jae-Hoon, AU - Oaks,Adam W, AU - Sidhu,Anita, Y1 - 2011/03/21/ PY - 2010/09/24/received PY - 2011/02/19/accepted PY - 2011/3/30/entrez PY - 2011/3/30/pubmed PY - 2011/8/4/medline SP - e17953 EP - e17953 JF - PloS one JO - PLoS One VL - 6 IS - 3 N2 - Tauopathic pathways lead to degenerative changes in Alzheimer's disease and there is evidence that they are also involved in the neurodegenerative pathology of Parkinson's disease [PD]. We have examined tauopathic changes in striatum of the α-synuclein (α-Syn) A53T mutant mouse. Elevated levels of α-Syn were observed in striatum of the adult A53T α-Syn mice. This was accompanied by increases in hyperphosphorylated Tau [p-Tau], phosphorylated at Ser202, Ser262 and Ser396/404, which are the same toxic sites also seen in Alzheimer's disease. There was an increase in active p-GSK-3β, hyperphosphorylated at Tyr216, a major and primary kinase known to phosphorylate Tau at multiple sites. The sites of hyperphosphorylation of Tau in the A53T mutant mice were similar to those seen in post-mortem striata from PD patients, attesting to their pathophysiological relevance. Increases in p-Tau were not due to alterations on protein phosphatases in either A53T mice or in human PD, suggesting lack of involvement of these proteins in tauopathy. Extraction of striata with Triton X-100 showed large increases in oligomeric forms of α-Syn suggesting that α-Syn had formed aggregates the mutant mice. In addition, increased levels of p-GSK-3β and pSer396/404 were also found associated with aggregated α-Syn. Differential solubilization to measure protein binding to cytoskeletal proteins demonstrated that p-Tau in the A53T mutant mouse were unbound to cytoskeletal proteins, consistent with dissociation of p-Tau from the microtubules upon hyperphosphorylation. Interestingly, α-Syn remained tightly bound to the cytoskeleton, while p-GSK-3β was seen in the cytoskeleton-free fractions. Immunohistochemical studies showed that α-Syn, pSer396/404 Tau and p-GSK-3β co-localized with one another and was aggregated and accumulated into large inclusion bodies, leading to cell death of Substantia nigral neurons. Together, these data demonstrate an elevated state of tauopathy in striata of the A53T α-Syn mutant mice, suggesting that tauopathy is a common feature of synucleinopathies. SN - 1932-6203 UR - https://www.unboundmedicine.com/medline/citation/21445308/Tauopathic_changes_in_the_striatum_of_A53T_α_synuclein_mutant_mouse_model_of_Parkinson's_disease_ L2 - https://dx.plos.org/10.1371/journal.pone.0017953 DB - PRIME DP - Unbound Medicine ER -